Otsuka Pharmaceutical
Director, Health Technology Assessment (HTA) Lead
Otsuka Pharmaceutical, Princeton, New Jersey, United States
Position Summary:
The Director, Health Technology Assessment (HTA) Lead, is responsible for leading the strategic development of HTA submissions. This role ensures that evidence generation activities are scientifically rigorous, strategically aligned, and operationally efficient to support global market access and reimbursement.
This position
can be based in Princeton, New Jersey. Otsuka maintains a hybrid work policy
and remote options will be considered for US candidates.
Key Responsibilities: Oversee the preparation of global value dossiers and HTA packages tailored to regional requirements. Support HTA/payer submissions by providing strategic guidance and coordinating among relevant functions to efficiently and effectively answer questions from HTA agencies. Ensure global and regional value evidence, medical, market access and government affairs teams are working seamlessly to execute HTA and payer submissions. Foster strong partnership with Data & Analytics to ensure seamless communication and collaboration for the development of global health economic models (e.g., cost-effectiveness, budget impact) to support HTA submissions and payer negotiations. Keep up to date with evolving HTA requirements and engage external experts, agencies, academic partners, and HTA bodies to obtain insights and ensure methodological robustness, relevance and to optimize submission strategies. Assess and inform Integrated Value Evidence Plans by ensuring HTA advice is captured.
Qualifications: Advanced degree (MS/PharmD/PhD) with focus in health economics, outcomes research, epidemiology, health services research, health policy, pharmaceutical administration or related field. Minimum 7 (PhD) to 10 (MS/PharmD) years of Pharmaceutical Company or payer experience in access, outcomes research, health economics, Health Technology Assessment or related area. Deep understanding of global HTA processes, payer evidence needs, and regulatory requirements. Hands on experience of interacting with HTA bodies and proven track record of successful HTA submissions. Experience in conducting HEOR studies. Scientific expertise in HTA/ HEOR. Experience in developing global value evidence strategy. Detailed understanding of healthy policy and reimbursement landscape. Strong project management and vendor oversight skills. Excellent communication, leadership, and stakeholder engagement capabilities. Strong business acumen and experience working as a part of cross functional team. Prior experience of working in Neuroscience or Nephrology area a plus
Preferred Qualifications: Experience with digital health data, advanced analytics, and innovative study designs. Familiarity with global market access strategies and lifecycle evidence planning. Experience working in a matrixed, global organization.
The Director, Health Technology Assessment (HTA) Lead, is responsible for leading the strategic development of HTA submissions. This role ensures that evidence generation activities are scientifically rigorous, strategically aligned, and operationally efficient to support global market access and reimbursement.
This position
can be based in Princeton, New Jersey. Otsuka maintains a hybrid work policy
and remote options will be considered for US candidates.
Key Responsibilities: Oversee the preparation of global value dossiers and HTA packages tailored to regional requirements. Support HTA/payer submissions by providing strategic guidance and coordinating among relevant functions to efficiently and effectively answer questions from HTA agencies. Ensure global and regional value evidence, medical, market access and government affairs teams are working seamlessly to execute HTA and payer submissions. Foster strong partnership with Data & Analytics to ensure seamless communication and collaboration for the development of global health economic models (e.g., cost-effectiveness, budget impact) to support HTA submissions and payer negotiations. Keep up to date with evolving HTA requirements and engage external experts, agencies, academic partners, and HTA bodies to obtain insights and ensure methodological robustness, relevance and to optimize submission strategies. Assess and inform Integrated Value Evidence Plans by ensuring HTA advice is captured.
Qualifications: Advanced degree (MS/PharmD/PhD) with focus in health economics, outcomes research, epidemiology, health services research, health policy, pharmaceutical administration or related field. Minimum 7 (PhD) to 10 (MS/PharmD) years of Pharmaceutical Company or payer experience in access, outcomes research, health economics, Health Technology Assessment or related area. Deep understanding of global HTA processes, payer evidence needs, and regulatory requirements. Hands on experience of interacting with HTA bodies and proven track record of successful HTA submissions. Experience in conducting HEOR studies. Scientific expertise in HTA/ HEOR. Experience in developing global value evidence strategy. Detailed understanding of healthy policy and reimbursement landscape. Strong project management and vendor oversight skills. Excellent communication, leadership, and stakeholder engagement capabilities. Strong business acumen and experience working as a part of cross functional team. Prior experience of working in Neuroscience or Nephrology area a plus
Preferred Qualifications: Experience with digital health data, advanced analytics, and innovative study designs. Familiarity with global market access strategies and lifecycle evidence planning. Experience working in a matrixed, global organization.